BioFlyte: Funding, Investors & Team (Sep 2026)
BioFlyte is commercializing a revolutionary new class of fieldable aerosol mass spectrometers and complementary products for protection from biological and low-volatility chemical threats. Our instruments identify microbes including spores, vegetative bacteria, and viruses, bio-toxins, opioids, and other airborne threats to our safety and security. Our products are designed to autonomously sample ambient air, for example, in critical infrastructure, but can also accept liquid or powder samples manually.
BioFlyte has raised $12.8M across 3 funding rounds on record, the most recent a Series B of $5.4M announced in Aug 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
BioFlyte Company Profile and Key Stats
Latest funding round on record: Aug 2023.
BioFlyte Funding Rounds
BioFlyte raised $1.3M in an undisclosed round announced in Jun 2020.
1.8 years later, a Series A of $6.1M was announced in Apr 2022.
1.3 years later, a Series B of $5.4M was announced in Aug 2023.
BioFlyte Founders and Leadership Team
No contact details are on record for this team yet.
BioFlyte Funding Compared to Other Biotechnology Startups
BioFlyte's latest round of $5.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like BioFlyte in Biotechnology and Albuquerque
Companies Similar to BioFlyte
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
BioFlyte Funding FAQs
What does BioFlyte do?
BioFlyte is commercializing a revolutionary new class of fieldable aerosol mass spectrometers and complementary products for protection from biological and low-volatility chemical threats. Our instruments identify microbes including spores, vegetative bacteria, and viruses, bio-toxins, opioids, and other airborne threats to our safety and security. Our products are designed to autonomously sample ambient air, for example, in critical infrastructure, but can also accept liquid or powder samples manually.
How much funding has BioFlyte raised?
BioFlyte has raised $12.8M across 3 rounds on record. The most recent is a Series B of $5.4M announced in Aug 2023.
When did BioFlyte last raise funding?
BioFlyte's most recent funding round on record is a Series B of $5.4M, announced in Aug 2023.
Who is the CEO of BioFlyte?
Charles Call is listed as CEO at BioFlyte.
Where is BioFlyte headquartered?
BioFlyte is based in Albuquerque, New Mexico, United States.
How many employees does BioFlyte have?
BioFlyte is in the 1-10 employee band.
How does BioFlyte's funding compare to other Biotechnology startups?
BioFlyte's latest round of $5.4M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's BioFlyte Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for BioFlyte is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.